Opening a new door into kinder, gentler therapies for chronic inflammation
Vaping combined with smoking is likely as harmful as smoking cigarettes alone
4 January 2021Public health officials in Chicago take data-driven approach to reopening city public schools
4 January 2021Opening a new door into kinder, gentler therapies for chronic inflammation
A naturally occurring antibody capable of stimulating the body’s immune-suppressing regulatory T cells has been discovered by a team of Harvard scientists, a finding that may eventually open a new door into kinder, gentler therapies for chronic inflammatory disorders.
